Clinic
Codman Square Health Center
Codman Square Health Center was paid $44.67M by Medicaid between Jan 2018 and Dec 2024, across 235 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoCODMAN SQUARE HEALTH CENTER
DORCHESTER CENTER, MA 02124
DORCHESTER CENTER, MA 02124
33aNPI1396808309assigned 12/19/2006
33bProvider typeCommunity Health Clinic/Center
28Total paid$44.67M
24GClaims996,443
24DCodes billed235
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in Massachusetts
Rank by total paid#5 of 36
Median peer was paid$3.62M
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 168,246 | $6.91M | |
| 2019 | 162,033 | $6.94M | |
| 2020 | 123,474 | $6.68M | |
| 2021 | 168,663 | $8.97M | |
| 2022 | 157,148 | $8.23M | |
| 2023 | 121,414 | $3.98M | |
| 2024incomplete | 95,465 | $2.95M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 201,872 | 181,184 | $15.78M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 108,981 | 101,397 | $9.21M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 6.7% | 41,006 | 35,565 | $3.00M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.3% | 18,165 | 17,372 | $1.47M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.5% | 13,638 | 13,380 | $1.12M |
| D9450 | 1.5% | 39,876 | 30,295 | $670K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 8,674 | 8,095 | $643K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 11,689 | 11,655 | $632K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.4% | 10,078 | 10,059 | $615K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.2% | 9,882 | 9,839 | $529K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.1% | 4,789 | 4,525 | $488K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.1% | 8,502 | 8,293 | $474K |
223 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 6,946 | $432K |
| 97802 | <1% | 6,570 | $381K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13,272 | $323K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,417 | $321K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13,117 | $319K |
| D1110 | Prophylaxis - adult | <1% | 7,246 | $301K |
| 99173 | <1% | 13,508 | $261K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 5,166 | $255K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 11,951 | $235K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12,695 | $235K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 3,798 | $233K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 4,528 | $229K |
| 90658 | <1% | 12,065 | $211K | |
| D1120 | Dental cleaning, child | <1% | 4,169 | $208K |
| 97803 | <1% | 3,461 | $201K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,238 | $196K |
| D0274 | Bitewings - four radiographic images | <1% | 6,376 | $196K |
| D0120 | Dental checkup, returning patient | <1% | 8,713 | $182K |
| D0140 | Limited oral evaluation - problem focused | <1% | 4,782 | $178K |
| 99050 | <1% | 10,302 | $174K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 2,330 | $170K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 14,832 | $153K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 3,566 | $141K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 4,816 | $138K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 2,597 | $133K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 6,528 | $132K |
| D1206 | Topical application of fluoride varnish | <1% | 5,119 | $131K |
| 92551 | <1% | 13,156 | $123K | |
| 90715 | <1% | 5,371 | $118K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 2,209 | $115K |
| 99381 | <1% | 1,153 | $114K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 15,765 | $111K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,282 | $110K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 884 | $103K |
| 99441 | <1% | 750 | $96K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 17,891 | $95K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 8,049 | $94K |
| 90651 | <1% | 2,427 | $91K | |
| D1351 | Sealant - per tooth | <1% | 2,305 | $91K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 20,846 | $89K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,973 | $89K |
| 86803 | <1% | 8,561 | $88K | |
| 92015 | Determination of refractive state | <1% | 6,834 | $86K |
| D0330 | Panoramic radiographic image | <1% | 1,389 | $79K |
| 86780 | <1% | 7,860 | $79K | |
| 90670 | <1% | 3,054 | $75K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 4,060 | $73K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,489 | $72K |
| 92552 | <1% | 2,520 | $66K | |
| 90649 | <1% | 824 | $58K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 3,925 | $56K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 696 | $53K |
| 90674 | <1% | 2,298 | $53K | |
| 99188 | <1% | 1,946 | $50K | |
| 0012A | <1% | 1,316 | $50K | |
| D4342 | <1% | 899 | $50K | |
| 0011A | <1% | 1,382 | $48K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 791 | $48K |
| 80061 | Lipid panel | <1% | 12,548 | $46K |
| 81025 | <1% | 8,147 | $46K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,584 | $45K |
| 90746 | <1% | 1,784 | $44K | |
| 0001A | <1% | 983 | $44K | |
| 90734 | <1% | 2,332 | $43K | |
| 85027 | <1% | 7,442 | $41K | |
| 0002A | <1% | 867 | $39K | |
| 90677 | <1% | 1,328 | $39K | |
| 91322 | <1% | 350 | $37K | |
| 90716 | <1% | 1,567 | $36K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 532 | $36K |
| 0004A | <1% | 771 | $33K | |
| 0064A | <1% | 735 | $30K | |
| 80053 | Comprehensive metabolic panel | <1% | 5,650 | $30K |
| D0272 | Bitewings - two radiographic images | <1% | 1,131 | $29K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 916 | $27K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 215 | $26K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 431 | $26K |
| 90633 | <1% | 2,676 | $26K | |
| 99385 | <1% | 400 | $25K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,491 | $25K |
| 90480 | <1% | 784 | $24K | |
| 90656 | <1% | 1,652 | $24K | |
| 82274 | <1% | 2,182 | $23K | |
| 0124A | <1% | 745 | $22K | |
| 0071A | <1% | 478 | $22K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 26 | $22K |
| 86706 | <1% | 2,802 | $21K | |
| 0072A | <1% | 418 | $19K | |
| 92133 | <1% | 874 | $18K | |
| 87340 | <1% | 2,233 | $18K | |
| 90621 | <1% | 658 | $17K | |
| 99051 | <1% | 3,104 | $16K | |
| 96127 | <1% | 1,651 | $16K | |
| 92341 | <1% | 440 | $16K | |
| 99442 | <1% | 643 | $16K | |
| 0134A | <1% | 543 | $16K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,338 | $14K |
| 90707 | <1% | 1,435 | $14K | |
| 81003 | <1% | 7,559 | $14K | |
| 82962 | <1% | 9,139 | $14K | |
| 99443 | <1% | 245 | $13K | |
| 86762 | <1% | 1,079 | $12K | |
| 86580 | <1% | 1,565 | $11K | |
| 98966 | <1% | 95 | $11K | |
| 90680 | <1% | 1,139 | $11K | |
| D4341 | <1% | 171 | $10K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 1,055 | $10K |
| 82043 | <1% | 2,354 | $10K | |
| 87210 | <1% | 2,565 | $9K | |
| 82948 | <1% | 2,703 | $9K | |
| 90750 | <1% | 194 | $8K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,424 | $8K |
| 82570 | <1% | 2,133 | $8K | |
| 87220 | <1% | 2,547 | $8K | |
| 99384 | <1% | 114 | $7K | |
| 90661 | <1% | 447 | $7K | |
| D2331 | <1% | 96 | $7K | |
| 99490 | Ccm add 20min | <1% | 164 | $7K |
| 90657 | <1% | 494 | $7K | |
| 90696 | <1% | 830 | $6K | |
| D0270 | <1% | 559 | $6K | |
| 90694 | <1% | 493 | $6K | |
| 99383 | <1% | 113 | $6K | |
| 92250 | <1% | 343 | $5K | |
| 90732 | <1% | 258 | $5K | |
| 80050 | General health panel | <1% | 318 | $5K |
| 86592 | <1% | 1,372 | $5K | |
| 0013A | <1% | 113 | $5K | |
| 99201 | <1% | 69 | $5K | |
| 11981 | <1% | 12 | $4K | |
| 92083 | <1% | 52 | $4K | |
| 99487 | Ccm add 20min | <1% | 183 | $4K |
| 90710 | <1% | 1,068 | $4K | |
| 81001 | <1% | 1,499 | $4K | |
| 73630 | <1% | 81 | $4K | |
| 73560 | <1% | 84 | $4K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 145 | $4K |
| 84450 | <1% | 1,504 | $4K | |
| 84460 | <1% | 1,483 | $3K | |
| D9110 | <1% | 100 | $3K | |
| 90713 | <1% | 389 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 552 | $3K |
| ATP14 | <1% | 267 | $2K | |
| 98967 | <1% | 13 | $2K | |
| 80069 | <1% | 401 | $2K | |
| 91320 | <1% | 89 | $2K | |
| 73610 | <1% | 53 | $2K | |
| 97804 | <1% | 42 | $2K | |
| 94664 | <1% | 325 | $2K | |
| 99397 | <1% | 44 | $2K | |
| 73130 | <1% | 29 | $2K | |
| D2330 | <1% | 35 | $2K | |
| 90714 | <1% | 54 | $2K | |
| 90653 | <1% | 75 | $2K | |
| 0081A | <1% | 43 | $2K | |
| D2150 | Silver amalgam - two surfaces, primary or permanent | <1% | 18 | $2K |
| 11721 | <1% | 116 | $1K | |
| D0180 | <1% | 47 | $1K | |
| 99172 | <1% | 91 | $1K | |
| 0154A | <1% | 32 | $1K | |
| 85610 | <1% | 345 | $1K | |
| 90461 | <1% | 1,194 | $1K | |
| 82950 | <1% | 257 | $1K | |
| 96160 | <1% | 318 | $1K | |
| 90648 | <1% | 1,469 | $1K | |
| 90620 | <1% | 343 | $1K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 40 | $997.90 |
| 90686 | <1% | 746 | $960.16 | |
| 73140 | <1% | 13 | $953.28 | |
| 82947 | <1% | 341 | $904.29 | |
| 90691 | <1% | 31 | $776.72 | |
| ATP08 | <1% | 93 | $660.66 | |
| 0074A | <1% | 36 | $652.98 | |
| ATP03 | <1% | 133 | $630.20 | |
| 0082A | <1% | 12 | $550.56 | |
| 0003A | <1% | 12 | $550.56 | |
| 73030 | <1% | 13 | $482.94 | |
| 80076 | <1% | 93 | $476.93 | |
| 90744 | <1% | 1,990 | $434.23 | |
| 90698 | <1% | 1,991 | $423.83 | |
| ATP17 | <1% | 39 | $405.89 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,960 | $394.57 |
| 90700 | <1% | 825 | $393.66 | |
| 84702 | <1% | 26 | $374.40 | |
| ATP11 | <1% | 43 | $373.51 | |
| 11056 | <1% | 25 | $345.89 | |
| 91301 | <1% | 2,800 | $313.88 | |
| G0008 | Administration of influenza virus vaccine | <1% | 165 | $283.66 |
| J3490 | Unclassified drugs | <1% | 15 | $273.84 |
| 36416 | <1% | 3,462 | $168.92 | |
| 99386 | <1% | 13 | $165.48 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 93 | $156.47 |
| 84100 | <1% | 29 | $101.89 | |
| 94760 | <1% | 116 | $37.95 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 50 | $27.02 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 26 | $19.56 |
| 83721 | <1% | 14 | $9.47 | |
| D0602 | 0% | 584 | $0.00 | |
| A9150 | Non-prescription drugs | 0% | 1,163 | $0.00 |
| 90723 | 0% | 441 | $0.00 | |
| D0603 | 0% | 546 | $0.00 | |
| D1330 | 0% | 161 | $0.00 | |
| 91307 | 0% | 835 | $0.00 | |
| D0601 | 0% | 174 | $0.00 | |
| D1320 | 0% | 660 | $0.00 | |
| 91315 | 0% | 45 | $0.00 | |
| 91306 | 0% | 618 | $0.00 | |
| D1310 | 0% | 141 | $0.00 | |
| D9995 | 0% | 54 | $0.00 | |
| 91319 | 0% | 14 | $0.00 | |
| 90473 | 0% | 477 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 68 | $0.00 |
| 91313 | 0% | 565 | $0.00 | |
| 91300 | 0% | 2,288 | $0.00 | |
| 91312 | 0% | 754 | $0.00 | |
| 90681 | 0% | 276 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 494 | $0.00 |
| 90671 | 0% | 42 | $0.00 | |
| 91321 | 0% | 20 | $0.00 | |
| 91308 | 0% | 87 | $0.00 | |
| 87999 | 0% | 14 | $0.00 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 0% | 12 | $0.00 |
| 91311 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFISH, GUY (CHIEF EXECUTIVE OFFICER)